Safety and clinical activity of atacicept in the long-term extension of the phase 2b ADDRESS II study in systemic lupus erythematosus.
Daniel J WallaceDavid Alan IsenbergEric F MorandCristina Vazquez-MateoAmy H KaoAida AydemirKishore PudotaVictor OnaCynthia AranowJoan T MerrillPublished in: Rheumatology (Oxford, England) (2021)
ClinicalTrials.gov, http://clinicaltrials.gov, NCT02070978.
Keyphrases